Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,551,301
  • Shares Outstanding, K 51,624
  • Annual Sales, $ 190,410 K
  • Annual Income, $ 20,890 K
  • EBIT $ 9 M
  • EBITDA $ 11 M
  • 60-Month Beta -3.16
  • Price/Sales 8.64
  • Price/Cash Flow 74.59
  • Price/Book 3.80

Options Overview Details

View History
  • Implied Volatility 87.25% (+4.28%)
  • Historical Volatility 51.58%
  • IV Percentile 85%
  • IV Rank 56.15%
  • IV High 124.05% on 10/20/25
  • IV Low 40.13% on 08/14/25
  • Expected Move (DTE 19) 3.66 (12.19%)
  • Put/Call Vol Ratio 8.54
  • Today's Volume 5,020
  • Volume Avg (30-Day) 2,382
  • Put/Call OI Ratio 1.25
  • Today's Open Interest 41,379
  • Open Int (30-Day) 39,292
  • Expected Range 26.39 to 33.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.73
  • Number of Estimates 6
  • High Estimate 0.93
  • Low Estimate 0.62
  • Prior Year -0.95
  • Growth Rate Est. (year over year) +176.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.43 +2.11%
on 03/27/26
41.86 -28.21%
on 03/02/26
-9.02 (-23.09%)
since 02/27/26
3-Month
29.43 +2.11%
on 03/27/26
50.88 -40.94%
on 01/08/26
-17.60 (-36.94%)
since 12/26/25
52-Week
29.43 +2.11%
on 03/27/26
90.32 -66.73%
on 07/09/25
-37.34 (-55.41%)
since 03/27/25

Most Recent Stories

More News
SLNO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options

SLNO : 30.05 (-5.68%)
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK and NEW ORLEANS , March 27, 2026 /PRNewswire/ -- Kahn Swick & Foti , LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in ...

SLNO : 30.05 (-5.68%)
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman

SLNO Investors with Losses Encouraged to Contact the Firm

SLNO : 30.05 (-5.68%)
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK , March 26, 2026 /PRNewswire/ --

SLNO : 30.05 (-5.68%)
SLNO Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages SLNO Investors with Losses to Contact the Firm

Did you buy SLNO common stock between March 26, 2025, and November 4, 202 5?

SLNO : 30.05 (-5.68%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLNO

NEW YORK , March 26, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO).   Such...

SLNO : 30.05 (-5.68%)
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting DCCR Safety Timeline: SueWallSt

Key Dates and Disclosure Events Shareholders Need to Know

SLNO : 30.05 (-5.68%)
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , March 25, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against...

SLNO : 30.05 (-5.68%)
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical Trials: Levi & Korsinsky

Alert: Claims Focus on Alleged Misrepresentations About Clinical Trial Integrity and Drug Safety

SLNO : 30.05 (-5.68%)
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Commercial Viability Risks: Levi & Korsinsky

Time-Sensitive: Allegations Focus on Undisclosed Commercial Viability and Adverse Event Risks

SLNO : 30.05 (-5.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 30%. The market has entered oversold territory.

See More Share

Business Summary

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief....

See More

Key Turning Points

3rd Resistance Point 34.74
2nd Resistance Point 33.55
1st Resistance Point 31.80
Last Price 30.05
1st Support Level 28.86
2nd Support Level 27.68
3rd Support Level 25.93

See More

52-Week High 90.32
Fibonacci 61.8% 67.06
Fibonacci 50% 59.87
Fibonacci 38.2% 52.69
Last Price 30.05
52-Week Low 29.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.